Global Induced Pluripotent Stem Cells Market Size & Outlook
Global induced pluripotent stem cells market, 2018-2030 (US$M)
Related Markets
Global induced pluripotent stem cells market highlights
- The global induced pluripotent stem cells market generated a revenue of USD 1,401.4 million in 2022 and is expected to reach USD 3,087.5 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 10.4% by 2030.
- In terms of segment, fibroblasts accounted for a revenue of USD 427.1 million in 2022.
- Hepatocytes is the most lucrative derived cell type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, Thailand is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 1,401.4 million |
| Market revenue in 2030 | USD 3,087.5 million |
| Growth rate | 10.4% (CAGR from 2022 to 2030) |
| Largest segment | Fibroblasts |
| Fastest growing segment | Hepatocytes |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells |
Other key industry trends
- In terms of revenue, the North America accounted for 42.4% of the global induced pluripotent stem cells market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Thailand is the fastest growing regional market and is projected to reach USD 23.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Induced Pluripotent Stem Cells Market Scope
Induced Pluripotent Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global induced pluripotent stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to induced pluripotent stem cells market will help companies and investors design strategic landscapes.
Fibroblasts was the largest segment with a revenue share of 30.48% in 2022. Horizon Databook has segmented the Global induced pluripotent stem cells market based on hepatocytes, fibroblasts, keratinocytes, amniotic cells covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Induced Pluripotent Stem Cells Derived Cell Type Outlook (Revenue, USD Million, 2018-2030)
- Hepatocytes
- Fibroblasts
- Keratinocytes
- Amniotic Cells
- Others
- Global Induced Pluripotent Stem Cells Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Development
- Toxicology Research
- Disease Modeling
- Tissue Engineering & Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Cardiovascular and Myocardial Infraction
- Diabetes
- Others
- Global Induced Pluripotent Stem Cells End Use Outlook (Revenue, USD Million, 2018-2030)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Reasons to subscribe to Global induced pluripotent stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global induced pluripotent stem cells market databook
-
Our clientele includes a mix of induced pluripotent stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global induced pluripotent stem cells market, including forecasts for subscribers. This global databook contains high-level insights into Global induced pluripotent stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global induced pluripotent stem cells market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Induced pluripotent stem cells market report size, 2022 (US$M)
Global induced pluripotent stem cells market report share, by derived cell type, 2022 & 2030 (%, US$M)
Induced pluripotent stem cells market: Opportunity assessment by country
Global induced pluripotent stem cells market, by region, 2022 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
